Binding Database

BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.7M data for 1.2M Compounds and 9.0K Targets. Of those, 1,244K data for 572K Compounds and 4.4K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

12 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID

Data

Article Title

Organization

Lead identification of 2-iminobenzimidazole antagonists of the chemokine receptor CXCR3.

Abbott Bioresearch Center

Discovery of potent and specific CXCR3 antagonists.

Amgen

Special ergolines efficiently inhibit the chemokine receptor CXCR3 in blood.

Novartis Institutes For Biomedical Research

II. SAR studies of pyridyl-piperazinyl-piperidine derivatives as CXCR3 chemokine antagonists.

Ligand Pharmaceuticals

Optimization of a series of quinazolinone-derived antagonists of CXCR3.

Amgen

Imidazo-pyrazine derivatives as potent CXCR3 antagonists.

Amgen

Special ergolines are highly selective, potent antagonists of the chemokine receptor CXCR3: discovery, characterization and preliminary SAR of a promising lead.

Novartis Institutes For Biomedical Research

Camphor sulfonamide derivatives as novel, potent and selective CXCR3 antagonists.

Glaxosmithkline

Development of CXCR3 antagonists. Part 3: Tropenyl and homotropenyl-piperidine urea derivatives.

Ucb Pharma

Identification and structure-activity relationships of 1-aryl-3-piperidin-4-yl-urea derivatives as CXCR3 receptor antagonists.

Ucb Pharma